Harbour Capital Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,807
Closed -$666K 323
2026
Q1
$666K Sell
5,807
-20
-0.3% -$2.61K 0.13% 155
2025
Q4
$715K Sell
5,827
-50
-0.9% -$6.27K 0.15% 143
2025
Q3
$677K Sell
5,877
-85
-1% -$9.95K 0.14% 150
2025
Q2
$761K Sell
5,962
-100
-2% -$11K 0.16% 136
2025
Q1
$430K Sell
6,062
-390
-6% -$26.8K 0.11% 183
2024
Q4
$446K Buy
6,452
+1,611
+33% +$150K 0.1% 191
2024
Q3
$664K Buy
4,841
+81
+2% +$12.5K 0.15% 142
2024
Q2
$715K Sell
4,760
-3,611
-43% -$433K 0.17% 128
2024
Q1
$608K Hold
8,371
0.15% 149
2023
Q4
$627K Buy
8,371
+140
+2% +$8.45K 0.17% 125
2023
Q3
$451K Buy
8,231
+1,190
+17% +$85.7K 0.14% 155
2023
Q2
$582K Sell
7,041
-100
-1% -$7.66K 0.17% 123
2023
Q1
$541K Buy
7,141
+1,975
+38% +$137K 0.16% 133
2022
Q4
$295K Buy
+5,166
New +$275K 0.1% 179
2020
Q2
Sell
-26,212
Closed -$317K 205
2020
Q1
$317K Buy
26,212
+5,312
+25% +$89K 0.16% 132
2019
Q4
$397K Buy
+20,900
New +$384K 0.15% 145

Other funds holding TMDX

Harbour Capital Advisors's TMDX Position: Q2 2026 in Review

Harbour Capital Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 5,807 shares — an estimated $666K sold.

Harbour Capital Advisors first reported a position in TMDX in Q4 2019 and held it in 16 quarters. The position peaked at $761K in Q2 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Harbour Capital Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Harbour Capital Advisors sold 5,807 Transmedics shares in Q2 2026, an estimated $666K.
  • Harbour Capital Advisors first reported a position in Transmedics in Q4 2019 and held it in 16 quarters.
  • Harbour Capital Advisors's Transmedics position peaked at $761K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.